<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report a case of a 13-year-old female with recurrent Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> who was heavily pretreated with chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>During chemotherapy for relapse, she developed serious <z:e sem="disease" ids="C0851807" disease_type="Disease or Syndrome" abbrv="">aspergillus infection</z:e> of the palate and sinuses </plain></SENT>
<SENT sid="2" pm="."><plain>Despite 10 microg/kg of filgrastim for 5 days, peripheral blood CD34(+) cells remained &lt;or=1/microL </plain></SENT>
<SENT sid="3" pm="."><plain>Hematopoietic progenitor cells were subsequently successfully mobilized with a combination of AMD3100 and filgrastim without <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> or fungus contamination </plain></SENT>
<SENT sid="4" pm="."><plain>After transplantation, the patient achieved complete engraftment without exacerbation of <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>This is the first case report of a pediatric patient with relapsed Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with mobilization of hematopoietic progenitor cells by AMD3100 without any adverse reactions </plain></SENT>
</text></document>